No profile data available.
Ishita Drugs and Industries Limited (ISHITADR.BO) is a healthcare company in the drug manufacturing contractors industry, based in Ahmedabad, India, with about 17 full-time employees.
It reported revenue of 146.60 million INR for fiscal year 2026, down 2.2% from fiscal year 2025, and net income of 7.78 million INR. In Q1 2027 (the quarter ended June 30, 2026) revenue was 31.45 million INR, down 41.8% from a year before. Its market capitalization was 227.26 million INR as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended March 31, 2026; market data as of October 9, 2026.
Ishita Drugs and Industries Limited engages in the manufacture and sale of active pharma ingredients (APIs), fine chemicals, drug intermediates, and excipients in India and internationally.
Ishita Drugs and Industries reported 146.60 million INR in revenue for fiscal year 2026, down 2.2% from 149.97 million INR in fiscal year 2025. In Q1 2027 revenue was 31.45 million INR.
227.26 million INR as of October 9, 2026.
Listed companies of a similar size in the same industry (drug manufacturing contractors) include Roopa Industries Limited (ROOPAIND.BO), Medi-Caps Limited (MEDICAPQ.BO), Samsrita Labs Limited (SAMSRITA.BO), Zenith Healthcare Limited (ZENITHHE.BO).